相似文献
1
Medical and Ethical Concerns Regarding Pacemaker Implantation in a Patient with Substance Use Disorder.
Cureus. 2018 Jul 22;10(7):e3027. doi: 10.7759/cureus.3027.
2
Principlist approach to multiple heart valve replacements for patients with intravenous drug use-induced endocarditis.
J Med Ethics. 2022 Jun 22. doi: 10.1136/medethics-2021-107685.
3
Do cardiologists and cardiac surgeons need ethics? Achieving happiness for a drug user with endocarditis.
Heart. 2009 Jun;95(11):885-7. doi: 10.1136/hrt.2008.163782. Epub 2009 Jan 23.
4
Pacemaker endocarditis in patients with prosthetic valve replacements: case trilogy and literature review.
Pacing Clin Electrophysiol. 2007 Oct;30(10):1279-83. doi: 10.1111/j.1540-8159.2007.00852.x.
5
Low pacemaker incidence with continuous-sutured valves: a retrospective analysis.
Asian Cardiovasc Thorac Ann. 2017 Jun;25(5):350-356. doi: 10.1177/0218492317712309. Epub 2017 May 22.
6
Complete atrioventricular block after isolated aortic valve replacement.
Kardiol Pol. 2016;74(9):985-93. doi: 10.5603/KP.a2016.0038. Epub 2016 Apr 4.
7
Etiology of tricuspid valve disease is a predictor of bradyarrhythmia after tricuspid valve surgery.
J Cardiovasc Electrophysiol. 2019 Jul;30(7):1108-1116. doi: 10.1111/jce.13937. Epub 2019 Apr 9.
8
The increased need for a permanent pacemaker after reoperative cardiac surgery.
J Thorac Cardiovasc Surg. 1998 Jul;116(1):74-81. doi: 10.1016/S0022-5223(98)70245-4.
9
[Cardiac device-related infective endocarditis as a late complication following permanent pacemaker implantation].
Kardiol Pol. 2011;69(3):265-9; discussion 274.
10
Medical ethics and ethical dilemmas.
Niger J Med. 2009 Jan-Mar;18(1):8-16.
本文引用的文献
1
Management of Device Infections.
Card Electrophysiol Clin. 2018 Mar;10(1):153-162. doi: 10.1016/j.ccep.2017.11.016.
2
Dilemmas in Dual Disease: Complexity and Futility in Prosthetic Valve Endocarditis and Substance Use Disorder.
Am J Bioeth. 2018 Jan;18(1):76-78. doi: 10.1080/15265161.2017.1401160.
3
The "Subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: An observational prospective multicenter study.
Int J Cardiol. 2018 Jan 1;250:146-149. doi: 10.1016/j.ijcard.2017.07.061. Epub 2017 Oct 9.
4
2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.
Heart Rhythm. 2017 Dec;14(12):e503-e551. doi: 10.1016/j.hrthm.2017.09.001. Epub 2017 Sep 15.
5
Low lateral thoracic site for cardiac implantable electronic device implantation: A viable alternative in patients with limited access options after infected device extraction.
Heart Rhythm. 2017 Oct;14(10):1506-1514. doi: 10.1016/j.hrthm.2017.06.004. Epub 2017 Jun 8.
6
Comparison of epicardial vs. endocardial reimplantation in pacemaker-dependent patients with device infection.
Europace. 2018 Apr 1;20(4):e42-e50. doi: 10.1093/europace/eux111.
7
Leadless Cardiac Pacemaker Implantation After Lead Extraction in Patients With Severe Device Infection.
J Cardiovasc Electrophysiol. 2016 Sep;27(9):1067-71. doi: 10.1111/jce.13030. Epub 2016 Jul 27.
8
Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.
Europace. 2015 May;17(5):767-77. doi: 10.1093/europace/euv053.
9
Comparison of delayed transvenous reimplantation and immediate surgical epicardial approach in pacing-dependent patients undergoing extraction of infected permanent pacemakers.
Heart Rhythm. 2015 Jun;12(6):1209-15. doi: 10.1016/j.hrthm.2015.02.023. Epub 2015 Feb 20.
10
Clinical classification and prognosis of isolated right-sided infective endocarditis.
Medicine (Baltimore). 2014 Dec;93(27):e137. doi: 10.1097/MD.0000000000000137.
Zotero 插件